$BWFG
Bankwell Financial Group, Inc. Stock $bwfg

$bwfg Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000150573221000113 Filed on May 07, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$18.78M	$20.10M
YoY Change	-6.56%	-6.43%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$791.0K	$830.0K
YoY Change	-4.7%	-1.43%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$4.122M	$6.810M
YoY Change	-39.47%	-5.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$7.269M	$1.514M
YoY Change	380.12%	-76.38%
Income Tax	$1.579M	$151.0K
% Of Pretax Income	21.72%	9.97%
Net Earnings	$5.690M	$1.363M
YoY Change	317.46%	-73.17%
Net Earnings / Revenue	30.3%	6.78%
Basic Earnings Per Share	$0.72	$0.17
Diluted Earnings Per Share	$0.71	$0.17
COMMON SHARES
Basic Shares Outstanding	7.759M shares	7.750M shares
Diluted Shares Outstanding	7.801M shares	7.779M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$362.0M	$210.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$33.39M	$27.84M
YoY Change	19.94%	-6.05%
Goodwill	$2.589M	$2.589M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.900M	$10.00M
YoY Change	-11.0%	108.33%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.244B	$2.054B
YoY Change	9.29%	8.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$46.40M	$52.10M
YoY Change	-10.94%	113.52%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$46.40M	$52.10M
YoY Change	-10.94%	113.52%
LONG-TERM LIABILITIES
Long-Term Debt	$25.30M	$25.20M
YoY Change	0.4%	0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$25.30M	$25.20M
YoY Change	0.4%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$46.40M	$52.10M
Total Long-Term Liabilities	$25.30M	$25.20M
Total Liabilities	$2.057B	$1.883B
YoY Change	9.19%	9.44%
SHAREHOLDERS EQUITY
Retained Earnings	$75.42M	$69.60M
YoY Change	8.37%	17.47%
Common Stock	$120.4M	$120.0M
YoY Change	0.37%	-0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$187.9M	$170.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.244B	$2.054B
YoY Change	9.29%	8.21%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$5.690M	$1.363M
YoY Change	317.46%	-73.17%
Depreciation, Depletion And Amortization	$791.0K	$830.0K
YoY Change	-4.7%	-1.43%
Cash From Operating Activities	$16.69M	-$16.84M
YoY Change	-199.12%	-3468.4%
INVESTING ACTIVITIES
Capital Expenditures	$2.646M	$40.00K
YoY Change	6515.0%	-65.52%
Acquisitions
YoY Change
Other Investing Activities	-$41.65M	-$13.29M
YoY Change	213.39%	-290.13%
Cash From Investing Activities	-$44.30M	-$13.33M
YoY Change	232.34%	-293.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.424M	$1.037M
YoY Change	37.32%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$19.99M	$162.1M
YoY Change	-112.33%	1899.46%
NET CHANGE
Cash From Operating Activities	$16.69M	-$16.84M
Cash From Investing Activities	-$44.30M	-$13.33M
Cash From Financing Activities	-$19.99M	$162.1M
Net Change In Cash	-$47.59M	$131.9M
YoY Change	-136.07%	752.41%
FREE CASH FLOW
Cash From Operating Activities	$16.69M	-$16.84M
Capital Expenditures	$2.646M	$40.00K
Free Cash Flow	$14.05M	-$16.88M
YoY Change	-183.21%	-4496.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001505732
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2207000	USD
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	88605000	USD
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Entity File Number EntityFileNumber	001-36448
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	Bankwell Financial Group, Inc.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CT
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-8251355
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	258 Elm Street
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New Canaan
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06840
CY2021Q1	dei	City Area Code CityAreaCode	203
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	652-0166
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value pershare
CY2021Q1	dei	Trading Symbol TradingSymbol	BWFG
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7908630	shares
CY2021Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	351194000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	405340000	USD
CY2021Q1	us-gaap	Federal Funds Sold FederalFundsSold	10811000	USD
CY2020Q4	us-gaap	Federal Funds Sold FederalFundsSold	4258000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	362005000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	409598000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2178000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	83218000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	18550000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	20032000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment	16225000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment	16078000	USD
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	101621000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	106890000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	20545000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21009000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1650127000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1601672000	USD
CY2021Q1	us-gaap	Interest Receivable InterestReceivable	7306000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	6579000	USD
CY2021Q1	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	6446000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	7860000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33386000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21762000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	42881000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	42651000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	2589000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2589000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	67000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	76000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8908000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11300000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	29131000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	42770000	USD
CY2021Q1	us-gaap	Assets Assets	2244467000	USD
CY2020Q4	us-gaap	Assets Assets	2253747000	USD
CY2021Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	280947000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	270235000	USD
CY2021Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1578861000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1557081000	USD
CY2021Q1	us-gaap	Deposits Deposits	1859808000	USD
CY2020Q4	us-gaap	Deposits Deposits	1827316000	USD
CY2021Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	125000000	USD
CY2020Q4	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	175000000	USD
CY2021Q1	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	25271000	USD
CY2020Q4	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	25258000	USD
CY2021Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	46445000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	49571000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	2056524000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2077145000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7908630	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7908630	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7919278	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7919278	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	120398000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	121338000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	75418000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	70839000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7873000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15575000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	187943000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	176602000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2244467000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2253747000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	17900000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	18985000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	769000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Securities InterestAndDividendIncomeSecurities	825000	USD
CY2021Q1	bwfg	Interest On Cash And Cash Equivalents InterestOnCashAndCashEquivalents	108000	USD
CY2020Q1	bwfg	Interest On Cash And Cash Equivalents InterestOnCashAndCashEquivalents	286000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18777000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	20096000	USD
CY2021Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3114000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	5709000	USD
CY2021Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1008000	USD
CY2020Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1101000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	4122000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	6810000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14655000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13286000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-296000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3185000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	243000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	14951000	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10101000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	513000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	231000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	199000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	217000	USD
CY2021Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1013000	USD
CY2020Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	612000	USD
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	1956000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	1072000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4769000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5380000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	2406000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	1909000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	587000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	711000	USD
CY2021Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	512000	USD
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	536000	USD
CY2021Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	403000	USD
CY2020Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	70000	USD
CY2021Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	317000	USD
CY2020Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	295000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	-9000	USD
CY2020Q1	us-gaap	Marketing Expense MarketingExpense	162000	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	653000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	596000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	9638000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	9659000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7269000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1514000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1579000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	151000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5690000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1363000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7758540	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7750135	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7800777	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7778762	shares
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5690000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1363000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1025000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1730000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2224000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent	-1025000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent	2224000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-227000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	494000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-798000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	10934000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	-17426000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	2434000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	-3878000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	8500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-13548000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7702000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11818000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13392000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10455000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	176602000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5690000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7702000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1111000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	431000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	53000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1424000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	187943000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	182397000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1363000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11818000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1092000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	385000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1037000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	170214000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5690000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1363000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-30000	USD
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-7000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-296000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3185000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	185000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-866000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-36000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	39000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	791000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	830000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	231000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	243000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	513000	USD
CY2020Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	431000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	385000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-6000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	403000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-4000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	727000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-92000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-11854000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	20000000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-181000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1591000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16694000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16842000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4329000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2312000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	4592000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	58000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7000	USD
CY2020Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	132000	USD
CY2021Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	4736000	USD
CY2020Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2021Q1	bwfg	Net Increase Decrease In Loan Balance NetIncreaseDecreaseInLoanBalance	47756000	USD
CY2020Q1	bwfg	Net Increase Decrease In Loan Balance NetIncreaseDecreaseInLoanBalance	16495000	USD
CY2021Q1	bwfg	Loan Principal Sold From Loans Not Originated For Sale LoanPrincipalSoldFromLoansNotOriginatedForSale	3967000	USD
CY2020Q1	bwfg	Loan Principal Sold From Loans Not Originated For Sale LoanPrincipalSoldFromLoansNotOriginatedForSale	0	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	4480000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	0	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2646000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	1414000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	968000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44297000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13329000	USD
CY2021Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-83269000	USD
CY2020Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	195674000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	115761000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Deposits IncreaseDecreaseInOtherDeposits	-6445000	USD
CY2021Q1	us-gaap	Increase Decrease In Loans From Other Federal Home Loan Banks IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks	-50000000	USD
CY2020Q1	us-gaap	Increase Decrease In Loans From Other Federal Home Loan Banks IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks	-25000000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	53000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1111000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1092000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1424000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1037000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19990000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	162116000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47593000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	131945000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	409598000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78051000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	362005000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	209996000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	4694000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	6503000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	109000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	63000	USD
CY2021Q1	bwfg	Noncash Financingand Investing Activities Net Changein Unrealized Gains Losseson Availablefor Sales Securities NoncashFinancingandInvestingActivitiesNetChangeinUnrealizedGainsLossesonAvailableforSalesSecurities	-1025000	USD
CY2020Q1	bwfg	Noncash Financingand Investing Activities Net Changein Unrealized Gains Losseson Availablefor Sales Securities NoncashFinancingandInvestingActivitiesNetChangeinUnrealizedGainsLossesonAvailableforSalesSecurities	2224000	USD
CY2021Q1	bwfg	Noncash Financingand Investing Activities Net Changein Unrealized Gains Losseson Derivative Instruments NoncashFinancingandInvestingActivitiesNetChangeinUnrealizedGainsLossesonDerivativeInstruments	10934000	USD
CY2020Q1	bwfg	Noncash Financingand Investing Activities Net Changein Unrealized Gains Losseson Derivative Instruments NoncashFinancingandInvestingActivitiesNetChangeinUnrealizedGainsLossesonDerivativeInstruments	-17426000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9775000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	103000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”) and general practices within the banking industry. In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities as of the date of the consolidated balance sheet, and revenue and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the allowance for loan losses, the valuation of derivative instruments, investment securities valuation, evaluation of investment securities for other than temporary impairment and deferred income taxes valuation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has resulted in significant economic disruption affecting our business and the clients we serve. As vaccination efforts have rapidly expanded, restrictions on businesses are being lifted and a return to more normal economic activity is expected. However, a significant degree of uncertainty still exists concerning the ultimate duration and magnitude of the COVID-19 pandemic. Given the ongoing and dynamic nature of the circumstances, it is still difficult to predict the full impact of the COVID-19 pandemic on our business. The extent of such impact will depend on future developments, including but not limited to the continued roll-out of vaccinations, which play an important role as to when the coronavirus can be controlled and abated.</span></div>
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts may be reclassified to conform to the 2021 financial statement presentation. These reclassifications only change the reporting categories and do not affect the consolidated results of operations or consolidated financial position of the Company.</span></div>
CY2021Q1	bwfg	Employee Retention Credit EmployeeRetentionCredit	900000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	80712000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2640000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	134000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	83218000	USD
CY2021Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	16225000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	2589000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	264000	USD
CY2021Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	18550000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	85074000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3531000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	88605000	USD
CY2020Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	16078000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	3954000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	0	USD
CY2020Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	20032000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2200000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	2100000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2200000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	2100000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	0	security
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	19099000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	398000	USD
CY2021Q1	bwfg	Debt Securities Securities Continuous Unrealized Loss Position Less Than Twelve Months Percentage Decline From Amortized Cost DebtSecuritiesSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsPercentageDeclineFromAmortizedCost	0.0204
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2021Q1	bwfg	Debt Securities Continuous Unrealized Loss Position Twelve Months Or Longer Percentage Decline From Amortized Cost DebtSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerPercentageDeclineFromAmortizedCost	0
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	19099000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	398000	USD
CY2021Q1	bwfg	Debt Securities Continuous Unrealized Loss Position Percentage Decline From Amortized Cost DebtSecuritiesContinuousUnrealizedLossPositionPercentageDeclineFromAmortizedCost	0.0204
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	6	security
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1673215000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1625627000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	20545000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21009000	USD
CY2021Q1	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	-2543000	USD
CY2020Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	-2946000	USD
CY2021Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1650127000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1601672000	USD
CY2021Q1	bwfg	Percentage Of Market Value Of Collateral PercentageOfMarketValueOfCollateral	0.80
CY2021Q1	bwfg	Private Mortgage Minimum Percentage Of Appraised Value Property PrivateMortgageMinimumPercentageOfAppraisedValueProperty	0.80
CY2021Q1	bwfg	Maximum Percent Of Loan In Comparison With Original Appraised Value Of Property MaximumPercentOfLoanInComparisonWithOriginalAppraisedValueOfProperty	0.80
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21009000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	177000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	9000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-296000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	20545000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13509000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	10000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	2000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3185000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16686000	USD
CY2021Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	59262000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	5612000	USD
CY2021Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1613953000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	14933000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1673215000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	20545000	USD
CY2021Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	59300000	USD
CY2020Q1	bwfg	Financing Receivable Individually Evaluated For Impairment Not Be Impaired FinancingReceivableIndividuallyEvaluatedForImpairmentNotBeImpaired	3200000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	57687000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	5045000	USD
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1567940000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	15964000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1625627000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21009000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	57700000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	39962000	USD
CY2020Q4	bwfg	Financing Receivable Individually Evaluated For Impairment Not Be Impaired FinancingReceivableIndividuallyEvaluatedForImpairmentNotBeImpaired	10000000.0	USD
CY2021Q1	bwfg	Deferred Loans DeferredLoans	300000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1633253000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1673215000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	15084000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1610543000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1625627000	USD
CY2021Q1	bwfg	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing Number Of Contracts FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruingNumberOfContracts	1	loan
CY2021Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	2700000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	31366000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	33416000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	400000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	200000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime	0	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Interest Income Recognized Change In Present Value Attributable To Passage Of Time LoansAndLeasesReceivableImpairedInterestIncomeRecognizedChangeInPresentValueAttributableToPassageOfTime	0	USD
CY2021Q1	bwfg	Financing Receivable Recorded Investment Nonaccrual With No Allowancefor Loan Losses Status Nonaccrual With No Allowancefor Loan Losses Status FinancingReceivableRecordedInvestmentNonaccrualWithNoAllowanceforLoanLossesStatusNonaccrualWithNoAllowanceforLoanLossesStatus	16300000	USD
CY2020Q4	bwfg	Financing Receivable Recorded Investment Nonaccrual With No Allowancefor Loan Losses Status Nonaccrual With No Allowancefor Loan Losses Status FinancingReceivableRecordedInvestmentNonaccrualWithNoAllowanceforLoanLossesStatusNonaccrualWithNoAllowanceforLoanLossesStatus	17500000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	22947000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	23751000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	24158000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	24899000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	33114000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	23955000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	33154000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	23971000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	5583000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	5045000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	56061000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	47706000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	57312000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	48870000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	5583000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	5045000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	23175000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	16426000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	60000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	104000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	33145000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	6220000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	557000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	34000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	56320000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	22646000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	617000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	138000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	9600000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	9100000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	loan
CY2021Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	1	loan
CY2020Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	loan
CY2021Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	631000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	0	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	631000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	0	USD
CY2021Q1	bwfg	Troubled Debt Restructuring Financing Receivable Non Accrual Status Count TroubledDebtRestructuringFinancingReceivableNonAccrualStatusCount	3	loan
CY2021Q1	bwfg	Troubled Debt Restructuring Financing Receivable Non Accrual Status TroubledDebtRestructuringFinancingReceivableNonAccrualStatus	1400000	USD
CY2020Q4	bwfg	Troubled Debt Restructuring Financing Receivable Non Accrual Status Count TroubledDebtRestructuringFinancingReceivableNonAccrualStatusCount	3	loan
CY2020Q4	bwfg	Troubled Debt Restructuring Financing Receivable Non Accrual Status TroubledDebtRestructuringFinancingReceivableNonAccrualStatus	1400000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	0	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	0	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	631000	USD
CY2020Q1	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	0	USD
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7908630	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7908630	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7919278	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7919278	shares
CY2018Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	400000	shares
CY2020	bwfg	Weighted Average Priceof Stock Repurchased During Period Per Shares WeightedAveragePriceofStockRepurchasedDuringPeriodPerShares	17.69
CY2021Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	6985000	USD
CY2021Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-717000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7702000	USD
CY2020Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-11867000	USD
CY2020Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-49000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11818000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	5690000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1363000	USD
CY2021Q1	bwfg	Dividends To Participating Securities DividendsToParticipatingSecurities	22000	USD
CY2020Q1	bwfg	Dividends To Participating Securities DividendsToParticipatingSecurities	17000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	94000	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	4000	USD
CY2021Q1	bwfg	Net Income Loss Available To Common Stockholders Basic Dividends And Undistributed Earnings NetIncomeLossAvailableToCommonStockholdersBasicDividendsAndUndistributedEarnings	5574000	USD
CY2020Q1	bwfg	Net Income Loss Available To Common Stockholders Basic Dividends And Undistributed Earnings NetIncomeLossAvailableToCommonStockholdersBasicDividendsAndUndistributedEarnings	1342000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7759000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7750000	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	42000	shares
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	29000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7801000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7779000	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2021Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.080
CY2021Q1	bwfg	Percentage Of Higher Risk Weight PercentageOfHigherRiskWeight	1.50
CY2021Q1	bwfg	Risk Weight Of Marketable Equity Securities RiskWeightOfMarketableEquitySecurities	3
CY2021Q1	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	198353000	USD
CY2021Q1	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1102
CY2021Q1	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	125966000	USD
CY2021Q1	bwfg	Common Equity Tier One Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0700
CY2021Q1	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	116968000	USD
CY2021Q1	bwfg	Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0650
CY2021Q1	us-gaap	Capital Capital	218998000	USD
CY2021Q1	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1217
CY2021Q1	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	188949000	USD
CY2021Q1	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.1050
CY2021Q1	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	179951000	USD
CY2021Q1	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.1000
CY2021Q1	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	198353000	USD
CY2021Q1	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1102
CY2021Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	152958000	USD
CY2021Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0850
CY2021Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	143961000	USD
CY2021Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0800
CY2021Q1	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	198353000	USD
CY2021Q1	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.0882
CY2021Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	89984000	USD
CY2021Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.0400
CY2021Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	112480000	USD
CY2021Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.0500
CY2020Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	191579000	USD
CY2020Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.1106
CY2020Q4	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	121216000	USD
CY2020Q4	bwfg	Common Equity Tier One Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0700
CY2020Q4	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	112558000	USD
CY2020Q4	bwfg	Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0650
CY2020Q4	us-gaap	Capital Capital	212588000	USD
CY2020Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.1228
CY2020Q4	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	181825000	USD
CY2020Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.1050
CY2020Q4	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	173166000	USD
CY2020Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.1000
CY2020Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	191579000	USD
CY2020Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.1106
CY2020Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	147191000	USD
CY2020Q4	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.0850
CY2020Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	138533000	USD
CY2020Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.0800
CY2020Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	191579000	USD
CY2020Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.0844
CY2020Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy TierOneLeverageCapitalRequiredForCapitalAdequacy	90836000	USD
CY2020Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.0400
CY2020Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	113545000	USD
CY2020Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.0500
CY2021Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	280947000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	270235000	USD
CY2021Q1	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	118489000	USD
CY2020Q4	us-gaap	Interest Bearing Domestic Deposit Negotiable Order Of Withdrawal Now InterestBearingDomesticDepositNegotiableOrderOfWithdrawalNOW	101737000	USD
CY2021Q1	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	751852000	USD
CY2020Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	669364000	USD
CY2021Q1	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	164559000	USD
CY2020Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	158750000	USD
CY2021Q1	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	543961000	USD
CY2020Q4	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	627230000	USD
CY2021Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1578861000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1557081000	USD
CY2021Q1	us-gaap	Deposits Deposits	1859808000	USD
CY2020Q4	us-gaap	Deposits Deposits	1827316000	USD
CY2021Q1	us-gaap	Time Deposit Maturities Remainder Of Fiscal Year TimeDepositMaturitiesRemainderOfFiscalYear	308621000	USD
CY2020Q4	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	418117000	USD
CY2021Q1	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	71564000	USD
CY2020Q4	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	50425000	USD
CY2021Q1	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	131027000	USD
CY2020Q4	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	128495000	USD
CY2021Q1	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	32716000	USD
CY2020Q4	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	30160000	USD
CY2021Q1	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	33000	USD
CY2020Q4	us-gaap	Time Deposit Maturities Year Five TimeDepositMaturitiesYearFive	33000	USD
CY2021Q1	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	543961000	USD
CY2020Q4	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	627230000	USD
CY2021Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	299800000	USD
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	353700000	USD
CY2021Q1	bwfg	Brokerage Certificate Of Deposits BrokerageCertificateOfDeposits	200100000	USD
CY2020Q4	bwfg	Brokerage Certificate Of Deposits BrokerageCertificateOfDeposits	238900000	USD
CY2021Q1	bwfg	Brokerage Certificate Of Deposits National Listing Service BrokerageCertificateOfDepositsNationalListingService	4900000	USD
CY2020Q4	bwfg	Brokerage Certificate Of Deposits National Listing Service BrokerageCertificateOfDepositsNationalListingService	18400000	USD
CY2021Q1	bwfg	Brokerage Money Market Accounts BrokerageMoneyMarketAccounts	53800000	USD
CY2020Q4	bwfg	Brokerage Money Market Accounts BrokerageMoneyMarketAccounts	13500000	USD
CY2021Q1	bwfg	Interest Expense Deposit Liabilities Notice Of Withdrawal And Money Market InterestExpenseDepositLiabilitiesNoticeOfWithdrawalAndMoneyMarket	43000	USD
CY2020Q1	bwfg	Interest Expense Deposit Liabilities Notice Of Withdrawal And Money Market InterestExpenseDepositLiabilitiesNoticeOfWithdrawalAndMoneyMarket	28000	USD
CY2021Q1	us-gaap	Interest Expense Domestic Deposit Liabilities Money Market InterestExpenseDomesticDepositLiabilitiesMoneyMarket	950000	USD
CY2020Q1	us-gaap	Interest Expense Domestic Deposit Liabilities Money Market InterestExpenseDomesticDepositLiabilitiesMoneyMarket	1492000	USD
CY2021Q1	us-gaap	Interest Expense Domestic Deposit Liabilities Savings InterestExpenseDomesticDepositLiabilitiesSavings	125000	USD
CY2020Q1	us-gaap	Interest Expense Domestic Deposit Liabilities Savings InterestExpenseDomesticDepositLiabilitiesSavings	672000	USD
CY2021Q1	us-gaap	Interest Expense Domestic Deposit Liabilities Time Deposit InterestExpenseDomesticDepositLiabilitiesTimeDeposit	1996000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	150	shares
CY2020Q1	us-gaap	Interest Expense Domestic Deposit Liabilities Time Deposit InterestExpenseDomesticDepositLiabilitiesTimeDeposit	3517000	USD
CY2021Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3114000	USD
CY2020Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	5709000	USD
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	112000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	163369	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	26.22
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	51628	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.97
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	28362	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	27.27
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	33.02
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	186485	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	24.05
CY2021Q1	bwfg	Rolling Period Of Federal Home Loan Bank Advances Converted To Fixed Rates RollingPeriodOfFederalHomeLoanBankAdvancesConvertedToFixedRates	P90D
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	10011000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-17488000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-923000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-62000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	2434000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	-3878000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	8500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-13548000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	2643000	USD
CY2021Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2021Q1	us-gaap	Derivative Assets DerivativeAssets	2643000	USD
CY2021Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	USD
CY2021Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	2643000	USD
CY2021Q1	bwfg	Accrued Interest Included In Fair Valueof Derivative Assets AccruedInterestIncludedInFairValueofDerivativeAssets	14000.0	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	15866000	USD
CY2021Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2021Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	15866000	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2021Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	15165000	USD
CY2021Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	701000	USD
CY2021Q1	bwfg	Accrued Interest Payable Included In Fair Valueof Derivative Liability AccruedInterestPayableIncludedInFairValueofDerivativeLiability	575900	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	4484000	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2020Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	28673000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	4484000	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	4484000	USD
CY2020Q4	bwfg	Accrued Interest Included In Fair Valueof Derivative Assets AccruedInterestIncludedInFairValueofDerivativeAssets	40000.0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	28673000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	28205000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	468000	USD
CY2020Q4	bwfg	Accrued Interest Payable Included In Fair Valueof Derivative Liability AccruedInterestPayableIncludedInFairValueofDerivativeLiability	662000.0	USD

Files In Submission

Name	View Source	Status
0001505732-21-000113-index-headers.html	Edgar Link	pending
0001505732-21-000113-index.html	Edgar Link	pending
0001505732-21-000113.txt	Edgar Link	pending
0001505732-21-000113-xbrl.zip	Edgar Link	pending
bwfg-20210331.htm	Edgar Link	pending
bwfg-20210331.xsd	Edgar Link	pending
bwfg-20210331_cal.xml	Edgar Link	unprocessable
bwfg-20210331_def.xml	Edgar Link	unprocessable
bwfg-20210331_htm.xml	Edgar Link	completed
bwfg-20210331_lab.xml	Edgar Link	unprocessable
bwfg-20210331_pre.xml	Edgar Link	unprocessable
bwfg03312021ex311.htm	Edgar Link	pending
bwfg03312021ex312.htm	Edgar Link	pending
bwfg03312021ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BWFG
Bankwell Financial Group, Inc. Stock $bwfg

2021 Q1 Form 10-Q Financial Statement

#000150573221000113 Filed on May 07, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BWFG Bankwell Financial Group, Inc. Stock $bwfg

2021 Q1 Form 10-Q Financial Statement

#000150573221000113 Filed on May 07, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BWFG
Bankwell Financial Group, Inc. Stock $bwfg